Tackling New Challenges with Lindsey Vonn

The rush of competition. Dedication to a singular goal. The unparalleled thrill of victory. These things drive professional athletes to push themselves well beyond the line where most of us would quit and turn back. The early morning workouts and carefully tailored lifestyle provide a structure and focus most of us couldn’t fathom. 

But, as the saying goes, time remains undefeated and a career as an elite athlete is temporary. When your entire life has been focused on reaching a specific goal, how do you reorient your entire being when that goal is suddenly gone?

For Lindsey Vonn, a decorated Olympian and one of the most successful downhill skiers of all time, the possibilities are endless, but that doesn’t mean the transition was easy. 

“When it finally came, it was still a hard transition, and everything that you’ve worked for your entire life is no longer something that you’re working for,” said Vonn. “You have to start fresh and it took me a bit to get into it, but it’s been a couple of years now and I’m really happy with where I am and the progress that I’ve made personally and professionally.”

Part of that progress involved writing a new book. Titled “Rise: My Story”, Vonn chronicles her career and the lessons she learned along the way, both on the slopes and off. It’s her hope that others can learn from her experiences.

“Hopefully it will help other people and inspire other people to overcome…whatever they’re facing.”

A crucial part of the adjustment process for many retired athletes is finding an outlet for all of their competitive energy. From coaching to broadcasting to investing, there are numerous examples of athletes taking up a new challenge when their days of competing are over. 

For Vonn, she has found the business world to be a challenge and an opportunity worthy of her time. But, what advice does she have for other athletes facing a similar transition? 

“Find what you’re passionate about. Obviously, as an athlete, you’re passionate about your sport, but when that’s gone, you have to find a new passion,” said Vonn. “You have to find something that challenges you, that excites you.”

While Vonn won’t be making headlines on the slopes anymore, it’s unlikely we’ve heard the last from her as she chases the next challenge. 

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More